A study for a 27 year old man who takes Niacin, L-Methylfolate, Omega-3, Fluoxetine - from FDA reports

Summary

21 males aged 27 (±5) who take the same drugs are studied. This is a personalized study for a 27 year old male patient who has Depression. The study is created by eHealthMe based on reports from FDA.



How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

What are the drugs?

What are the conditions?

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Jan, 10, 2019

21 males aged 27 (±5) who take Niacin, L-Methylfolate, Omega-3, Fluoxetine are studied.


Number of reports submitted per year:

Niacin, L-Methylfolate, Omega-3, Fluoxetine for a 27-year old man.

Information of the patient in this study:

  • Age: 27
  • Gender: male
  • Conditions: Depression
  • Drugs taken:
    • Niacin (niacin)
    • L-Methylfolate (folic acid)
    • Omega-3 (cod liver oil)
    • Fluoxetine (fluoxetine hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
n/a
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  2. Pancreatitis acute (sudden inflammation of pancreas)
  3. Pancreatitis (inflammation of pancreas)
2 - 5 years:
  1. Gallbladder disorder
  2. Injury
  3. Haemoglobin decreased
  4. Emotional distress
  5. Gallstones (stone formation by bile component)
  6. Abdominal pain
  7. Jaundice - yellow skin (a yellowish pigmentation of the skin)
  8. Pain
  9. Chest pain
  10. Cholecystitis chronic (long lasting infection of gallbladder)
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Weight decreased
  2. Small intestinal obstruction (blockage in small intestine)
  3. Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus)
  4. Enlarged cerebral perivascular spaces
  5. Gallstones (stone formation by bile component)
  6. Agitation (state of anxiety or nervous excitement)
  7. Sedation
  8. Catheter site inflammation (infection at catheter site)
  9. Swallowing difficulty
  10. Pain

Top conditions involved for these people *:

  1. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 4 people, 19.05%
  2. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 3 people, 14.29%
  3. Iron Deficiency : 2 people, 9.52%
  4. Psoriasis (immune-mediated disease that affects the skin): 2 people, 9.52%
  5. Diarrhea : 1 person, 4.76%
  6. Hyperthyroidism (over activity of the thyroid gland): 1 person, 4.76%
  7. Hallucinations (sensations that appear real but are created by your mind): 1 person, 4.76%
  8. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid): 1 person, 4.76%
  9. Gender Identity Disorder (men or women identify better with the opposite sex): 1 person, 4.76%
  10. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 1 person, 4.76%

Top co-used drugs for these people *:

  1. Abilify (6 people, 28.57%)
  2. Lamictal (5 people, 23.81%)
  3. Humira (4 people, 19.05%)
  4. Apriso (3 people, 14.29%)
  5. Soliris (3 people, 14.29%)
  6. Acetaminophen (3 people, 14.29%)
  7. Xanax (3 people, 14.29%)
  8. Ambien (2 people, 9.52%)
  9. Propylthiouracil (2 people, 9.52%)
  10. Potassium (2 people, 9.52%)

* Some reports may have incomplete information.

What is next?

You are not alone:


Related publications that referenced our studies



Related studies:



FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.